Cargando…

Costs of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation – a nationwide cohort study

BACKGROUND: Use of oral anticoagulation therapy in patients with atrial fibrillation (AF) involves a trade-off between a reduced risk of ischemic stroke and an increased risk of bleeding events. Different anticoagulation therapies have different safety profiles and data on the societal costs of both...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jakobsen, Marie, Kolodziejczyk, Christophe, Klausen Fredslund, Eskild, Poulsen, Peter Bo, Dybro, Lars, Paaske Johnsen, Søren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469002/ https://www.ncbi.nlm.nih.gov/pubmed/28606079 http://dx.doi.org/10.1186/s12913-017-2331-z

Ejemplares similares

Erratum to: costs of major intracranial, gastrointestinal and other bleeding events in patients with atrial fibrillation – a nationwide cohort study
por: Jakobsen, Marie, et al.
Publicado: (2017)

Setting priorities in the health care sector – the case of oral anticoagulants in nonvalvular atrial fibrillation in Denmark
por: Poulsen, Peter Bo, et al.
Publicado: (2017)

Cost of illness of atrial fibrillation: a nationwide study of societal impact
por: Johnsen, Søren Paaske, et al.
Publicado: (2017)

Newly diagnosed atrial fibrillation and hospital utilization in heart failure: a nationwide cohort study
por: Vinter, Nicklas, et al.
Publicado: (2021)

Can the Easter break induce a long-term break of exercise routines? An analysis of Danish gym data using a regression discontinuity design
por: Fredslund, Eskild Klausen, et al.
Publicado: (2019)

Atrial fibrillation in patients with ischemic stroke: A population-based study
por: Thygesen, Sandra Kruchov, et al.
Publicado: (2009)

Clinical events preceding switching and discontinuation of oral anticoagulant treatment in patients with atrial fibrillation
por: Hellfritzsch, Maja, et al.
Publicado: (2017)

Opportunistic screening for atrial fibrillation in a real-life setting in general practice in Denmark—The Atrial Fibrillation Found On Routine Detection (AFFORD) non-interventional study
por: Hald, Jonas, et al.
Publicado: (2017)

Association of preceding antithrombotic therapy in atrial fibrillation patients with ischaemic stroke, intracranial haemorrhage, or gastrointestinal bleed and mortality
por: Komen, Joris J, et al.
Publicado: (2019)

Effects of rivaroxaban and warfarin on the risk of gastrointestinal bleeding and intracranial hemorrhage in patients with atrial fibrillation: Systematic review and meta‐analysis
por: Jiang, Hongcheng, et al.
Publicado: (2021)

Challenges of Anticoagulant Therapy in Atrial Fibrillation—Focus on Gastrointestinal Bleeding
por: Scridon, Alina, et al.
Publicado: (2023)

Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study
por: Staerk, Laila, et al.
Publicado: (2015)

Life-Years Lost After Newly Diagnosed Atrial Fibrillation in Patients with Heart Failure
por: Vinter, Nicklas, et al.
Publicado: (2022)

Risk factors and prevention of dabigatran‐related gastrointestinal bleeding in patients with atrial fibrillation
por: Nantsupawat, Teerapat, et al.
Publicado: (2017)

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding
por: Lip, Gregory Y. H., et al.
Publicado: (2021)

Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants
por: Ording, Anne Gulbech, et al.
Publicado: (2021)

Electrical energy by electrode placement for cardioversion of atrial fibrillation: a systematic review and meta-analysis
por: Vinter, Nicklas, et al.
Publicado: (2023)

Development and validation of prediction models for incident atrial fibrillation in heart failure
por: Vinter, Nicklas, et al.
Publicado: (2023)

Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation
por: Yong, Celina M., et al.
Publicado: (2020)

Association Between Bipolar Disorder or Schizophrenia and Oral Anticoagulation Use in Danish Adults With Incident or Prevalent Atrial Fibrillation
por: Fenger-Grøn, Morten, et al.
Publicado: (2021)

Cardiovascular disease in women with breast cancer – a nationwide cohort study
por: Jakobsen, Marie, et al.
Publicado: (2021)

Atrial fibrillation in patients with severe mental disorders and the risk of stroke, fatal thromboembolic events and bleeding: a nationwide cohort study
por: Søgaard, Mette, et al.
Publicado: (2017)

Effectiveness and safety of direct oral anticoagulants in atrial fibrillation patients switched from vitamin K antagonists: A systematic review and meta‐analysis
por: Hellfritzsch, Maja, et al.
Publicado: (2019)

The impact of frailty on the management of atrial fibrillation
por: Harrison, Stephanie L., et al.
Publicado: (2023)

Stroke and Bleeding Risk in Atrial Fibrillation
por: Senoo, Keitaro, et al.
Publicado: (2014)

Socioeconomic inequality in oral anticoagulation therapy initiation in patients with atrial fibrillation with high risk of stroke: a register-based observational study
por: Lunde, Elin Danielsen, et al.
Publicado: (2021)

Feasibility of Left Atrial Appendage Closure in Atrial Fibrillation Patients with a History of Intracranial Bleeding: A Systematic Review of Observational Studies
por: Ajmal, Muhammad, et al.
Publicado: (2020)

Socioeconomic factors and bleeding events in patients with incident atrial fibrillation: A Finnish nationwide cohort study
por: Teppo, Konsta, et al.
Publicado: (2022)

Geographical Variation in the Use of Oral Anticoagulation and Clinical Outcomes among Patients with Atrial Fibrillation in Denmark, Sweden, and Finland
por: Frost, Lars, et al.
Publicado: (2023)

Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients
por: Deitelzweig, Steven, et al.
Publicado: (2021)

Management of Gastrointestinal Bleeding and Resumption of Oral Anticoagulant Therapy in Patients with Atrial Fibrillation: A Multidisciplinary Discussion
por: Martin, Anne-Céline, et al.
Publicado: (2023)

Increasing emergency hospital activity in Denmark, 2005–2016: a nationwide descriptive study
por: Fløjstrup, Marianne, et al.
Publicado: (2020)

Restarting anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation: A nationwide retrospective cohort study
por: Moon, Jong Youn, et al.
Publicado: (2022)

A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants
por: Halvorsen, Sigrun, et al.
Publicado: (2017)

Burden-of-Illness Associated with Bleeding-Related Hospitalizations in Atrial Fibrillation Patients: Findings from the Nationwide Readmission Database
por: Miao, Benjamin, et al.
Publicado: (2020)

GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study
por: Dalgaard, Frederik, et al.
Publicado: (2019)

Gastrointestinal comorbidities associated with atrial fibrillation
por: Laliberté, François, et al.
Publicado: (2014)

Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life
por: Zappulla, Paolo, et al.
Publicado: (2021)

Bleeding Risk Scores in Atrial Fibrillation: Helpful or Harmful?
por: Edmiston, Marissa K., et al.
Publicado: (2018)

Racial differences in atrial fibrillation-related bleeding and mortality
por: Kang, D S, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v88gs7l5uioiloi9ao3lsouoas